Jeffrey W Liu, MD
Ophthalmology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 5 carriers
- Office
- 1
Offices
1 location · Peninsula Laser Eye Medical Group Inc · 4 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
25 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liu’s office at (650) 961-2585 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A114765 · Current
Licensed to practise in California · since 2010 · expires 2028-09-30 · Brown University Program in Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$344,508
Medicare paid this office $344,508 for 894 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 545 | $60,982 | $111 |
| Removal of cataract with insertion of prosthetic lens | 69 | $53,765 | $532 |
| Return visit (30+ min) | 237 | $45,953 | $117 |
| Short return visit (20+ min) | 277 | $38,215 | $85 |
| Removal of recurring cataract in lens capsule using a laser | 34 | $14,260 | $340 |
See all 20 services
| Established patient complete exam of visual system | 545 | $60,982 | $111 |
| Removal of cataract with insertion of prosthetic lens | 69 | $53,765 | $532 |
| Return visit (30+ min) | 237 | $45,953 | $117 |
| Short return visit (20+ min) | 277 | $38,215 | $85 |
| Removal of recurring cataract in lens capsule using a laser | 34 | $14,260 | $340 |
| Laser repair to improve eye fluid flow | 22 | $11,504 | $349 |
| New patient complete exam of visual system | 93 | $11,152 | $120 |
| Photography of the retina | 279 | $10,480 | $35 |
| Exam of visual field with extended testing | 134 | $9,384 | $63 |
| Imaging of retina | 196 | $8,683 | $39 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $8,631 | $719 |
| New patient visit (45+ min) | 51 | $7,642 | $150 |
| Imaging of optic nerve | 189 | $6,414 | $33 |
| Closure of tear duct opening using plug | 22 | $6,028 | $194 |
| Measurement of corneal curvature and depth of eye | 85 | $4,556 | $39 |
| Ct scan of cornea | 41 | $1,814 | $34 |
| New patient visit (30+ min) | 16 | $1,612 | $101 |
| Removal of eyelashes using forceps | 16 | $758 | $19 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 32 | $604 | $15 |
| Ultrasound scan of cornea to determine thickness | 26 | $384 | $11 |
Procedures Medicare counted
| Cataract surgery | 153 | More than 80% of doctors who do this |
Who their Medicare patients are
894 Original Medicare patients in 2024. Average age 77 · Women 57% · Also on Medicaid 7% · Health risk score 0.94. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 63% · Coronary heart disease 24% · Diabetes 23% · Cancer 19% · Atrial fibrillation 16% · Chronic kidney disease 15% · Heart failure 11% · Depression 11% · Stroke 7% · COPD 6% · Dementia 4%.
The office billed $936,556, Medicare allowed $463,919 and paid $344,508; for 3,013 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 894 | 3,013 | 77 | 0.94 | $936,556 | $344,508 |
| 2023 | 892 | 2,728 | 78 | 0.94 | $909,408 | $318,024 |
| 2022 | 844 | 2,535 | 78 | 0.93 | $810,418 | $282,774 |
| 2021 | 808 | 2,487 | 78 | 0.94 | $768,220 | $301,537 |
| 2020 | 727 | 2,183 | 78 | 1.02 | $655,472 | $237,276 |
| 2019 | 908 | 2,562 | 77 | 1.00 | $787,750 | $289,905 |
| 2018 | 847 | 2,507 | 77 | 0.97 | $729,452 | $259,600 |
| 2017 | 857 | 2,518 | 77 | 0.99 | $645,273 | $241,840 |
| 2016 | 710 | 2,097 | 77 | 1.06 | $498,792 | $196,874 |
| 2015 | 737 | 1,969 | 76 | 1.00 | $487,307 | $199,371 |
| 2014 | 435 | 810 | 76 | 1.05 | $267,526 | $84,594 |
| 2013 | 27 | 33 | 68 | 1.37 | $36,203 | $2,561 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Removal of cataract with insertion of prosthetic lens | 80 | $59,311 | $503 |
| Established patient complete exam of visual system | 496 | $55,408 | $110 |
| Return visit (30+ min) | 262 | $46,499 | $110 |
| Short return visit (20+ min) | 210 | $28,631 | $83 |
| New patient complete exam of visual system | 176 | $22,243 | $126 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $12,722 | $707 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $11,869 | $339 |
| Imaging of retina | 183 | $8,050 | $38 |
| Exam of visual field with extended testing | 109 | $7,260 | $59 |
| Laser repair to improve eye fluid flow | 14 | $6,093 | $321 |
| Imaging of optic nerve | 174 | $6,022 | $33 |
| Photography of the retina | 150 | $5,795 | $35 |
| Closure of tear duct opening using plug | 18 | $5,721 | $212 |
| New patient visit (45+ min) | 36 | $5,469 | $152 |
| Measurement of corneal curvature and depth of eye | 95 | $5,277 | $39 |
| Ct scan of cornea | 32 | $1,386 | $37 |
| Removal of eyelashes using forceps | 15 | $806 | $18 |
| Imaging of front third of eye using a special microscope | 17 | $617 | $36 |
| Ultrasound scan of cornea to determine thickness | 27 | $358 | $11 |
2022: 17 services
| Removal of cataract with insertion of prosthetic lens | 71 | $55,490 | $519 |
| Established patient complete exam of visual system | 522 | $55,106 | $105 |
| Return visit (30+ min) | 270 | $48,482 | $108 |
| Short return visit (20+ min) | 195 | $20,292 | $75 |
| New patient complete exam of visual system | 102 | $12,274 | $120 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $9,422 | $337 |
| Exam of visual field with extended testing | 110 | $6,732 | $60 |
| Imaging of retina | 156 | $6,150 | $36 |
| New patient visit (45+ min) | 42 | $5,806 | $138 |
| Imaging of optic nerve | 177 | $5,708 | $31 |
| Photography of the retina | 162 | $5,372 | $31 |
| Closure of tear duct opening using plug | 19 | $5,322 | $184 |
| Measurement of corneal curvature and depth of eye | 76 | $4,220 | $38 |
| Ct scan of cornea | 27 | $810 | $28 |
| Removal of eyelashes using forceps | 17 | $786 | $17 |
| Imaging of front third of eye using a special microscope | 12 | $526 | $40 |
| Ultrasound scan of cornea to determine thickness | 24 | $365 | $11 |
2021: 22 services
| Established patient complete exam of visual system | 519 | $55,302 | $106 |
| Removal of cataract with insertion of prosthetic lens | 49 | $41,854 | $517 |
| Return visit (30+ min) | 191 | $38,423 | $118 |
| Short return visit (20+ min) | 232 | $26,365 | $78 |
| Laser repair to improve eye fluid flow | 19 | $9,811 | $338 |
| New patient complete exam of visual system | 75 | $9,436 | $126 |
| Exam of visual field with extended testing | 123 | $8,430 | $62 |
| Removal of recurring cataract in lens capsule using a laser | 20 | $7,793 | $339 |
| Imaging of retina | 175 | $7,193 | $38 |
| New patient visit (45+ min) | 46 | $7,088 | $154 |
| Imaging of optic nerve | 193 | $6,767 | $34 |
| Closure of tear duct opening using plug | 21 | $6,080 | $203 |
| Measurement of corneal curvature and depth of eye | 66 | $4,727 | $47 |
| Established patient problem focused exam of visual system | 61 | $4,457 | $69 |
| Ct scan of cornea | 41 | $1,716 | $35 |
| New patient visit (30+ min) | 18 | $1,698 | $94 |
| Dilation of tear drainage opening | 11 | $1,341 | $103 |
| Photography of the retina | 30 | $1,262 | $41 |
| Imaging of front third of eye using a special microscope | 25 | $977 | $38 |
| Removal of eyelashes using forceps | 16 | $676 | $23 |
| Exam of the internal drainage system of eye | 12 | $342 | $29 |
| Ultrasound scan of cornea to determine thickness | 25 | $332 | $10 |
2020: 20 services
| Established patient complete exam of visual system | 452 | $47,128 | $103 |
| Removal of cataract with insertion of prosthetic lens | 43 | $36,375 | $527 |
| Short return visit (20+ min) | 238 | $28,347 | $66 |
| Established patient problem focused exam of visual system | 111 | $13,530 | $77 |
| Return visit (30+ min) | 105 | $12,718 | $91 |
| New patient complete exam of visual system | 78 | $9,165 | $118 |
| Laser repair to improve eye fluid flow | 17 | $7,552 | $315 |
| Exam of visual field with extended testing | 106 | $7,529 | $61 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $7,002 | $333 |
| Imaging of optic nerve | 180 | $6,468 | $35 |
| Closure of tear duct opening using plug | 23 | $6,384 | $206 |
| Imaging of retina | 119 | $5,109 | $38 |
| Measurement of corneal curvature and depth of eye | 50 | $3,502 | $47 |
| New patient visit (30+ min) | 24 | $1,925 | $80 |
| Ct scan of cornea | 23 | $1,031 | $37 |
| New patient visit (15+ min) | 11 | $769 | $70 |
| Imaging of front third of eye using a special microscope | 15 | $514 | $34 |
| Removal of eyelashes using forceps | 11 | $362 | $26 |
| Exam of the internal drainage system of eye | 12 | $297 | $25 |
| Ultrasound scan of cornea to determine thickness | 15 | $168 | $10 |
2019: 21 services
| Removal of cataract with insertion of prosthetic lens | 63 | $58,972 | $614 |
| Established patient complete exam of visual system | 581 | $58,695 | $100 |
| Established patient problem focused exam of visual system | 195 | $29,663 | $80 |
| Short return visit (20+ min) | 205 | $20,633 | $65 |
| New patient complete exam of visual system | 101 | $12,643 | $125 |
| Return visit (30+ min) | 104 | $9,743 | $89 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $9,278 | $320 |
| Exam of visual field with extended testing | 120 | $7,330 | $57 |
| Laser repair to improve eye fluid flow | 13 | $7,324 | $318 |
| Imaging of optic nerve | 197 | $6,675 | $33 |
| Imaging of retina | 160 | $6,380 | $37 |
| Measurement of corneal curvature and depth of eye | 75 | $6,021 | $55 |
| Closure of tear duct opening using plug | 19 | $5,394 | $186 |
| Ct scan of cornea | 35 | $1,360 | $37 |
| New patient problem focused exam of visual system | 16 | $1,249 | $78 |
| New patient visit (30+ min) | 12 | $1,158 | $96 |
| Removal of eyelashes using forceps | 15 | $628 | $29 |
| Imaging of front third of eye using a special microscope | 17 | $613 | $36 |
| Examination of eye by ophthalmoscope with retinal drawing | 17 | $496 | $22 |
| Examination of eye by ophthalmoscope with retinal drawing | 15 | $347 | $23 |
| Ultrasound scan of cornea to determine thickness | 27 | $322 | $11 |
2018: 19 services
| Removal of cataract with insertion of prosthetic lens | 61 | $54,796 | $596 |
| Established patient complete exam of visual system | 527 | $53,265 | $99 |
| Short return visit (20+ min) | 325 | $38,285 | $60 |
| Transplantation of outer layer of corneal tissue | 11 | $12,056 | $1,005 |
| Established patient problem focused exam of visual system | 110 | $11,886 | $81 |
| Return visit (30+ min) | 104 | $11,039 | $89 |
| New patient complete exam of visual system | 103 | $10,791 | $105 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $7,065 | $307 |
| Imaging of optic nerve | 187 | $6,432 | $34 |
| Exam of visual field with extended testing | 103 | $6,290 | $58 |
| Closure of tear duct opening using plug | 23 | $6,099 | $197 |
| Measurement of corneal curvature and depth of eye | 63 | $5,615 | $63 |
| Imaging of retina | 135 | $5,317 | $37 |
| New patient visit (30+ min) | 24 | $2,044 | $85 |
| Ct scan of cornea | 33 | $1,439 | $36 |
| New patient problem focused exam of visual system | 12 | $771 | $64 |
| Examination of eye by ophthalmoscope with retinal drawing | 24 | $765 | $25 |
| Imaging of front third of eye using a special microscope | 18 | $621 | $34 |
| Ultrasound scan of cornea to determine thickness | 15 | $220 | $14 |
2017: 19 services
| Established patient complete exam of visual system | 539 | $54,677 | $99 |
| Removal of cataract with insertion of prosthetic lens | 51 | $48,614 | $608 |
| Short return visit (20+ min) | 348 | $47,041 | $63 |
| New patient complete exam of visual system | 100 | $11,951 | $120 |
| Return visit (30+ min) | 80 | $9,221 | $95 |
| Exam of visual field with extended testing | 118 | $7,939 | $62 |
| Imaging of optic nerve | 181 | $6,349 | $33 |
| Measurement of corneal curvature and depth of eye | 62 | $5,754 | $69 |
| Closure of tear duct opening using plug | 21 | $5,290 | $189 |
| Imaging of retina | 121 | $4,981 | $37 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $4,601 | $307 |
| Established patient problem focused exam of visual system | 57 | $4,190 | $70 |
| Imaging of front third of eye using a special microscope | 33 | $1,220 | $36 |
| Removal of eyelashes using forceps | 14 | $1,119 | $47 |
| Ct scan of cornea | 23 | $976 | $36 |
| Ultrasound scan of cornea to determine thickness | 35 | $660 | $13 |
| Examination of eye by ophthalmoscope with retinal drawing | 20 | $567 | $25 |
| Examination of eye by ophthalmoscope with retinal drawing | 15 | $478 | $22 |
| Exam of the internal drainage system of eye | 15 | $409 | $26 |
2016: 21 services
| Short return visit (20+ min) | 361 | $49,586 | $60 |
| Established patient complete exam of visual system | 376 | $37,272 | $98 |
| Removal of cataract with insertion of prosthetic lens | 22 | $19,184 | $581 |
| Removal of recurring cataract in lens capsule using a laser | 28 | $10,200 | $309 |
| Closure of tear duct opening using plug | 36 | $8,448 | $188 |
| New patient complete exam of visual system | 69 | $7,752 | $112 |
| Laser repair to improve eye fluid flow | 14 | $7,485 | $356 |
| Return visit (30+ min) | 58 | $5,758 | $90 |
| Exam of visual field with extended testing | 83 | $5,017 | $57 |
| Imaging of retina | 90 | $4,085 | $41 |
| Imaging of optic nerve | 101 | $4,008 | $39 |
| Measurement of corneal curvature and depth of eye | 27 | $2,757 | $73 |
| New patient visit (30+ min) | 26 | $2,093 | $81 |
| Ct scan of cornea | 26 | $1,282 | $36 |
| Removal of eyelashes using forceps | 16 | $923 | $46 |
| Examination of eye by ophthalmoscope with retinal drawing | 28 | $862 | $21 |
| New patient visit (15+ min) | 14 | $766 | $55 |
| Imaging of front third of eye using a special microscope | 17 | $567 | $31 |
| Examination of eye by ophthalmoscope with retinal drawing | 17 | $490 | $18 |
| Ultrasound scan of cornea to determine thickness | 21 | $343 | $14 |
| Exam of the internal drainage system of eye | 11 | $274 | $25 |
2015: 20 services
| Short return visit (20+ min) | 346 | $43,878 | $63 |
| Established patient complete exam of visual system | 408 | $41,556 | $100 |
| Removal of cataract with insertion of prosthetic lens | 22 | $18,497 | $597 |
| Closure of tear duct opening using plug | 47 | $10,683 | $191 |
| New patient complete exam of visual system | 65 | $8,052 | $124 |
| Return visit (30+ min) | 65 | $5,749 | $85 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $4,497 | $321 |
| Exam of visual field with extended testing | 61 | $4,299 | $63 |
| Imaging of retina | 84 | $3,817 | $43 |
| Imaging of optic nerve | 83 | $3,441 | $41 |
| Measurement of corneal curvature and depth of eye | 31 | $2,947 | $76 |
| New patient visit (30+ min) | 27 | $2,277 | $84 |
| Examination of eye by ophthalmoscope with retinal drawing | 36 | $1,105 | $21 |
| Removal of eyelashes using forceps | 16 | $967 | $51 |
| Examination of eye by ophthalmoscope with retinal drawing | 27 | $835 | $23 |
| Ct scan of cornea | 14 | $749 | $37 |
| New patient visit (15+ min) | 11 | $639 | $58 |
| Imaging of front third of eye using a special microscope | 15 | $503 | $34 |
| Ultrasound scan of cornea to determine thickness | 24 | $394 | $13 |
| Exam of the internal drainage system of eye | 15 | $367 | $24 |
2014: 15 services
| Established patient complete exam of visual system | 186 | $21,400 | $114 |
| Short return visit (20+ min) | 124 | $12,515 | $67 |
| Return visit (30+ min) | 57 | $6,705 | $100 |
| Transplantation of outer layer of corneal tissue | 14 | $5,688 | $335 |
| New patient complete exam of visual system | 29 | $3,545 | $122 |
| Exam of visual field with extended testing | 25 | $1,663 | $64 |
| Imaging of optic nerve | 38 | $1,617 | $43 |
| Imaging of retina | 25 | $1,100 | $44 |
| New patient visit (30+ min) | 11 | $1,023 | $93 |
| Short return visit (20+ min) | 18 | $958 | $40 |
| Return visit (30+ min) | 12 | $674 | $56 |
| Examination of eye by ophthalmoscope with retinal drawing | 12 | $466 | $26 |
| Imaging of retina | 13 | $336 | $26 |
| Exam of the internal drainage system of eye | 11 | $286 | $26 |
| Ultrasound scan of cornea to determine thickness | 11 | $169 | $14 |
2013: 1 service
| Short return visit (20+ min) | 12 | $553 | $40 |
Drugs they prescribed that Part D paid
$117,047
Pharmacies billed $117,047 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,057) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
539 generic and 518 brand-name prescriptions · $117,047 in drug cost · 23 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 13 | $23,827 | $1,833 |
| Xdemvy | 12 | $22,042 | $1,837 |
| Prednisolone Acetate | 190 | $6,809 | $36 |
| Lumigan | 16 | $6,741 | $421 |
| Latanoprost | 218 | $3,195 | $15 |
See all 21 drugs
| Restasis | 13 | $23,827 | $1,833 |
| Xdemvy | 12 | $22,042 | $1,837 |
| Prednisolone Acetate | 190 | $6,809 | $36 |
| Lumigan | 16 | $6,741 | $421 |
| Latanoprost | 218 | $3,195 | $15 |
| Fluorometholone | 46 | $2,994 | $65 |
| Tafluprost | 15 | $2,806 | $187 |
| Valacyclovir | 25 | $2,696 | $108 |
| Tobramycin-Dexamethasone | 65 | $2,640 | $41 |
| Travoprost | 15 | $2,092 | $139 |
| Brimonidine Tartrate-Timolol | 14 | $2,087 | $149 |
| Loteprednol Etabonate | 18 | $2,026 | $113 |
| Timolol Maleate | 65 | $1,839 | $28 |
| Brimonidine | 33 | $1,608 | $49 |
| Dorzolamide-Timolol | 56 | $872 | $16 |
| Ofloxacin | 63 | $733 | $12 |
| Moxifloxacin | 13 | $302 | $23 |
| Erythromycin | 20 | $280 | $14 |
| Diclofenac | 32 | $234 | $7 |
| Doxycycline Monohydrate | 13 | $213 | $16 |
| Neomycin-Polymyxin-Dexameth | 13 | $115 | $9 |
Year by year
| 2024 | 1,057 | 303 | 0% (0) | 49% | $117,047 |
| 2023 | 889 | 265 | None | 54% | $110,217 |
| 2022 | 942 | 249 | None | 51% | $229,133 |
| 2021 | 1,088 | 272 | None | 57% | $152,780 |
| 2020 | 1,090 | 297 | None | 51% | $233,702 |
| 2019 | 1,096 | 298 | None | 49% | $131,737 |
| 2018 | 1,160 | 295 | None | 50% | $116,688 |
| 2017 | 1,022 | 265 | None | 48% | $104,683 |
| 2016 | 734 | 212 | None | 54% | $74,576 |
| 2015 | 839 | 241 | 0% (0) | 52% | $77,297 |
| 2014 | 639 | 222 | None | 66% | $91,241 |
| 2013 | 129 | 57 | 0% (0) | 74% | $16,929 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Restasis | 16 | $28,500 | $1,781 |
| Lumigan | 24 | $11,383 | $474 |
| Cequa | 18 | $11,094 | $616 |
| Prednisolone Acetate | 139 | $5,794 | $42 |
| Latanoprost | 206 | $5,651 | $27 |
| Timolol Maleate | 58 | $3,847 | $66 |
| Tobradex St | 13 | $3,142 | $242 |
| Brimonidine Tartrate-Timolol | 11 | $2,699 | $245 |
| Valacyclovir | 13 | $2,609 | $201 |
| Combigan | 13 | $2,538 | $195 |
| Fluorometholone | 36 | $2,512 | $70 |
| Travoprost | 15 | $2,364 | $158 |
| Brimonidine | 19 | $1,545 | $81 |
| Tobramycin-Dexamethasone | 26 | $1,286 | $49 |
| Dorzolamide-Timolol | 46 | $939 | $20 |
| Ofloxacin | 57 | $862 | $15 |
| Moxifloxacin | 14 | $461 | $33 |
| Erythromycin | 26 | $291 | $11 |
| Diclofenac | 19 | $212 | $11 |
| Acyclovir | 16 | $184 | $11 |
2022: 19 drugs
| Restasis | 22 | $36,271 | $1,649 |
| Lumigan | 26 | $13,502 | $519 |
| Combigan | 35 | $11,235 | $321 |
| Cequa | 14 | $8,744 | $625 |
| Latanoprost | 229 | $6,444 | $28 |
| Prednisolone Acetate | 114 | $5,285 | $46 |
| Brimonidine Tartrate-Timolol | 17 | $4,059 | $239 |
| Valacyclovir | 28 | $3,854 | $138 |
| Travoprost | 19 | $3,327 | $175 |
| Fluorometholone | 33 | $2,255 | $68 |
| Tobramycin-Dexamethasone | 27 | $1,870 | $69 |
| Dorzolamide-Timolol | 70 | $1,725 | $25 |
| Timolol Maleate | 68 | $1,593 | $23 |
| Brimonidine | 20 | $898 | $45 |
| Moxifloxacin | 15 | $741 | $49 |
| Ofloxacin | 49 | $543 | $11 |
| Dorzolamide | 11 | $447 | $41 |
| Erythromycin | 28 | $321 | $11 |
| Acyclovir | 12 | $115 | $10 |
2021: 18 drugs
| Restasis | 29 | $41,567 | $1,433 |
| Lumigan | 25 | $14,179 | $567 |
| Combigan | 36 | $13,954 | $388 |
| Cequa | 14 | $9,603 | $686 |
| Prednisolone Acetate | 145 | $7,331 | $51 |
| Latanoprost | 250 | $6,151 | $25 |
| Tobradex | 25 | $6,095 | $244 |
| Travoprost | 22 | $4,496 | $204 |
| Tobramycin-Dexamethasone | 38 | $2,906 | $76 |
| Valacyclovir | 17 | $2,648 | $156 |
| Fluorometholone | 28 | $2,140 | $76 |
| Dorzolamide-Timolol | 65 | $2,100 | $32 |
| Ofloxacin | 105 | $1,351 | $13 |
| Brimonidine | 14 | $909 | $65 |
| Doxycycline Monohydrate | 19 | $646 | $34 |
| Timolol Maleate | 46 | $593 | $13 |
| Diclofenac | 47 | $579 | $12 |
| Moxifloxacin | 16 | $422 | $26 |
2020: 20 drugs
| Restasis | 25 | $30,361 | $1,214 |
| Lumigan | 26 | $9,070 | $349 |
| Combigan | 23 | $8,112 | $353 |
| Tobramycin-Dexamethasone | 87 | $7,970 | $92 |
| Prednisolone Acetate | 137 | $6,837 | $50 |
| Travoprost | 30 | $5,741 | $191 |
| Tobradex | 23 | $5,617 | $244 |
| Latanoprost | 207 | $4,553 | $22 |
| Valacyclovir | 22 | $3,053 | $139 |
| Dorzolamide-Timolol | 53 | $2,825 | $53 |
| Pazeo | 11 | $2,336 | $212 |
| Ofloxacin | 104 | $1,407 | $14 |
| Fluorometholone | 16 | $1,125 | $70 |
| Timolol Maleate | 65 | $1,032 | $16 |
| Olopatadine | 12 | $640 | $53 |
| Moxifloxacin | 14 | $605 | $43 |
| Ketorolac Tromethamine | 18 | $485 | $27 |
| Diclofenac | 29 | $368 | $13 |
| Doxycycline Monohydrate | 20 | $274 | $14 |
| Brimonidine | 26 | $232 | $9 |
2019: 22 drugs
| Restasis | 29 | $37,652 | $1,298 |
| Xiidra | 12 | $13,954 | $1,163 |
| Travatan Z | 35 | $9,187 | $262 |
| Prednisolone Acetate | 148 | $7,549 | $51 |
| Tobramycin-Dexamethasone | 82 | $7,005 | $85 |
| Combigan | 18 | $6,276 | $349 |
| Lumigan | 17 | $5,645 | $332 |
| Lotemax | 20 | $4,634 | $232 |
| Latanoprost | 175 | $4,080 | $23 |
| Zioptan | 12 | $2,676 | $223 |
| Timolol Maleate | 71 | $2,502 | $35 |
| Dorzolamide-Timolol | 15 | $2,266 | $151 |
| Valacyclovir | 18 | $2,236 | $124 |
| Ofloxacin | 133 | $1,989 | $15 |
| Dorzolamide-Timolol | 35 | $1,915 | $55 |
| Ketorolac Tromethamine | 62 | $1,785 | $29 |
| Fluorometholone | 17 | $1,235 | $73 |
| Olopatadine | 17 | $989 | $58 |
| Brimonidine | 39 | $721 | $18 |
| Azelastine | 18 | $437 | $24 |
| Acyclovir | 13 | $322 | $25 |
| Diclofenac | 11 | $125 | $11 |
2018: 24 drugs
| Restasis | 22 | $20,626 | $938 |
| Prednisolone Acetate | 212 | $11,960 | $56 |
| Xiidra | 16 | $11,675 | $730 |
| Travatan Z | 27 | $6,836 | $253 |
| Tobramycin-Dexamethasone | 60 | $4,596 | $77 |
| Lotemax | 20 | $4,588 | $229 |
| Prolensa | 13 | $3,623 | $279 |
| Latanoprost | 163 | $3,513 | $22 |
| Lumigan | 17 | $3,404 | $200 |
| Zioptan | 13 | $2,899 | $223 |
| Cosopt Pf | 15 | $2,503 | $167 |
| Dorzolamide-Timolol | 51 | $1,827 | $36 |
| Ofloxacin | 137 | $1,809 | $13 |
| Timolol Maleate | 86 | $1,620 | $19 |
| Ketorolac Tromethamine | 41 | $1,473 | $36 |
| Brimonidine | 44 | $1,331 | $30 |
| Valacyclovir | 11 | $719 | $65 |
| Fluorometholone | 11 | $694 | $63 |
| Azelastine | 13 | $620 | $48 |
| Dorzolamide | 15 | $545 | $36 |
| Acyclovir | 13 | $336 | $26 |
| Neomycin-Polymyxin-Dexameth | 14 | $207 | $15 |
| Diclofenac | 15 | $204 | $14 |
| Erythromycin | 15 | $179 | $12 |
2017: 20 drugs
| Restasis | 35 | $27,907 | $797 |
| Prednisolone Acetate | 160 | $10,449 | $65 |
| Travatan Z | 36 | $8,353 | $232 |
| Alphagan P | 37 | $6,434 | $174 |
| Tobramycin-Dexamethasone | 55 | $4,468 | $81 |
| Prolensa | 13 | $3,597 | $277 |
| Latanoprost | 146 | $3,576 | $24 |
| Lotemax | 17 | $3,114 | $183 |
| Cosopt Pf | 17 | $2,679 | $158 |
| Lumigan | 11 | $2,285 | $208 |
| Zioptan | 12 | $2,173 | $181 |
| Dorzolamide-Timolol | 59 | $2,118 | $36 |
| Ofloxacin | 116 | $1,689 | $15 |
| Combigan | 11 | $1,661 | $151 |
| Timolol Maleate | 44 | $1,288 | $29 |
| Valacyclovir | 17 | $1,139 | $67 |
| Diclofenac | 56 | $880 | $16 |
| Brimonidine | 30 | $685 | $23 |
| Neomycin-Polymyxin-Dexameth | 11 | $177 | $16 |
| Acyclovir | 14 | $127 | $9 |
2016: 18 drugs
| Restasis | 26 | $19,764 | $760 |
| Prednisolone Acetate | 103 | $6,719 | $65 |
| Alphagan P | 30 | $4,448 | $148 |
| Travatan Z | 24 | $4,181 | $174 |
| Tobramycin-Dexamethasone | 54 | $3,974 | $74 |
| Lotemax | 23 | $3,754 | $163 |
| Ilevro | 15 | $3,572 | $238 |
| Zioptan | 14 | $2,365 | $169 |
| Cosopt Pf | 11 | $1,600 | $145 |
| Latanoprost | 69 | $1,505 | $22 |
| Valacyclovir | 29 | $1,388 | $48 |
| Dorzolamide-Timolol | 40 | $1,328 | $33 |
| Ofloxacin | 68 | $1,066 | $16 |
| Fluorometholone | 23 | $986 | $43 |
| Diclofenac | 27 | $333 | $12 |
| Neomycin-Polymyxin-Dexameth | 13 | $204 | $16 |
| Timolol Maleate | 15 | $185 | $12 |
| Erythromycin | 12 | $130 | $11 |
2015: 18 drugs
| Restasis | 40 | $20,217 | $505 |
| Prednisolone Acetate | 150 | $10,204 | $68 |
| Pataday | 18 | $4,751 | $264 |
| Tobramycin-Dexamethasone | 50 | $4,507 | $90 |
| Valacyclovir | 27 | $3,350 | $124 |
| Prolensa | 12 | $2,542 | $212 |
| Lotemax | 15 | $2,471 | $165 |
| Methazolamide | 13 | $2,418 | $186 |
| Ofloxacin | 130 | $2,088 | $16 |
| Fluorometholone | 17 | $1,171 | $69 |
| Latanoprost | 77 | $1,054 | $14 |
| Dorzolamide-Timolol | 52 | $980 | $19 |
| Timolol Maleate | 20 | $960 | $48 |
| Brimonidine | 14 | $594 | $42 |
| Diclofenac | 47 | $429 | $9 |
| Acyclovir | 11 | $250 | $23 |
| Neomycin-Polymyxin-Dexameth | 13 | $211 | $16 |
| Erythromycin | 15 | $190 | $13 |
2014: 13 drugs
| Restasis | 111 | $48,225 | $434 |
| Prednisolone Acetate | 118 | $7,765 | $66 |
| Lotemax | 27 | $4,624 | $171 |
| Vigamox | 34 | $4,583 | $135 |
| Doxycycline Hyclate | 16 | $2,094 | $131 |
| Tobramycin-Dexamethasone | 24 | $2,054 | $86 |
| Brimonidine | 12 | $1,734 | $144 |
| Fluorometholone | 21 | $1,115 | $53 |
| Acyclovir | 42 | $1,027 | $24 |
| Ofloxacin | 43 | $638 | $15 |
| Dorzolamide-Timolol | 14 | $565 | $40 |
| Latanoprost | 16 | $268 | $17 |
| Diclofenac | 15 | $175 | $12 |
2013: 3 drugs
| Restasis | 25 | $8,656 | $346 |
| Vigamox | 17 | $1,675 | $99 |
| Prednisolone Acetate | 31 | $849 | $27 |
Money from drug and device companies
$825 in 2025
| 2025 | 10 | 74 | $28 | $825 |
| 2024 | 9 | 48 | None | $622 |
| 2023 | 6 | 9 | None | $306 |
| 2022 | 11 | 35 | None | $596 |
| 2021 | 8 | 40 | None | $462 |
| 2020 | 7 | 42 | None | $592 |
| 2019 | 8 | 44 | None | $764 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | Xdemvy | $247 | 53 payments
|
| Biotissue Holdings | None | $200 | 6 payments
|
| Abbvie | Lumigan | $72 | 3 payments
|
| Dompe US | Oxervate | $65 | 2 payments
|
| Bausch & Lomb Americas | Vyzulta | $59 | 3 payments
|
| Alcon Vision | Tryptyr | $53 | 2 payments
|
See all 74 published payments
| Tarsus Pharmaceuticals | Meals · 2025-12-12 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-12-11 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-12-03 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-12-02 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-11-19 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-11-18 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-11-12 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-11-12 | Xdemvy | $2 |
| Oyster Point Pharma | Meals · 2025-11-11 | Tyrvaya | $17 |
| Tarsus Pharmaceuticals | Meals · 2025-10-21 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-10-21 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-10-01 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-09-30 | Xdemvy | $5 |
| Alcon Vision | Meals · 2025-09-25 | Tryptyr | $31 |
| Tarsus Pharmaceuticals | Meals · 2025-09-22 | Xdemvy | $19 |
| Tarsus Pharmaceuticals | Meals · 2025-09-19 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-09-18 | Xdemvy | $3 |
| Dompe US | Meals · 2025-09-16 | Oxervate | $31 |
| Mallinckrodt Hospital Products | Meals · 2025-09-09 | Acthar | $38 |
| Bausch & Lomb Americas | Meals · 2025-09-09 | Vyzulta | $26 |
| Tarsus Pharmaceuticals | Meals · 2025-09-03 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-09-02 | Xdemvy | $5 |
| RxSight | Meals · 2025-08-28 | Rxsight Contact Lens | $19 |
| RxSight | Honoraria · 2025-08-26 | Rxsight Contact Lens | $28 |
| Tarsus Pharmaceuticals | Meals · 2025-08-20 | Xdemvy | $2 |
| Tarsus Pharmaceuticals | Meals · 2025-08-19 | Xdemvy | $4 |
| Harrow Eye | Meals · 2025-08-19 | Iheezo | $28 |
| Bausch & Lomb Americas | Meals · 2025-08-14 | Miebo | $15 |
| Tarsus Pharmaceuticals | Meals · 2025-07-29 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-07-29 | Xdemvy | $4 |
| Abbvie | Meals · 2025-07-24 | Lumigan | $25 |
| Tarsus Pharmaceuticals | Meals · 2025-07-10 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-07-10 | Xdemvy | $2 |
| Tarsus Pharmaceuticals | Meals · 2025-07-08 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-07-08 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-06-24 | Xdemvy | $25 |
| Biotissue Holdings | Meals · 2025-06-18 | None | $25 |
| Tarsus Pharmaceuticals | Meals · 2025-06-17 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-06-17 | Xdemvy | $3 |
| Biotissue Holdings | Meals · 2025-06-10 | None | $25 |
| Tarsus Pharmaceuticals | Meals · 2025-06-03 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-06-03 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-05-29 | Xdemvy | $4 |
| Biotissue Holdings | Meals · 2025-05-29 | None | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-05-28 | Xdemvy | $3 |
| Abbvie | Meals · 2025-05-22 | Lumigan | $25 |
| Alcon Vision | Meals · 2025-05-20 | Clareon | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-05-20 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-05-20 | Xdemvy | $5 |
| Biotissue Holdings | Meals · 2025-05-14 | None | $25 |
| Tarsus Pharmaceuticals | Meals · 2025-05-13 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-05-13 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-04-22 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-04-22 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-04-16 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-04-16 | Xdemvy | $5 |
| Biotissue Holdings | Meals · 2025-04-15 | None | $65 |
| Tarsus Pharmaceuticals | Meals · 2025-04-08 | Xdemvy | $19 |
| Tarsus Pharmaceuticals | Meals · 2025-03-27 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-03-27 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-03-19 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-03-19 | Xdemvy | $3 |
| Biotissue Holdings | Meals · 2025-03-19 | None | $40 |
| Tarsus Pharmaceuticals | Meals · 2025-03-11 | Xdemvy | $2 |
| Tarsus Pharmaceuticals | Meals · 2025-03-11 | Xdemvy | $6 |
| Abbvie | Meals · 2025-02-25 | Lumigan | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-02-25 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-02-25 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-02-11 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-02-11 | Xdemvy | $3 |
| Dompe US | Meals · 2025-01-30 | Oxervate | $33 |
| Bausch & Lomb Americas | Meals · 2025-01-21 | Xiidra | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-01-14 | Xdemvy | $4 |
| Tarsus Pharmaceuticals | Meals · 2025-01-14 | Xdemvy | $4 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $622
| Biotissue Holdings | None | $261 | 5 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $181 | 35 payments
|
| Bausch & Lomb Americas | Miebo | $45 | 2 payments
|
| Dompe US | Oxervate | $25 | 1 payment
|
| Alcon Vision | Clareon | $24 | 1 payment
|
| Harrow Eye | Ilevro | $24 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $24 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $23 | 1 payment
|
| Johnson & Johnson Surgical Vision | None | $15 | 1 payment
|
2023: $306
| RxSight | Rxsight Contact Lens | $128 | 2 payments
|
| Alcon Vision | Clareon | $71 | 2 payments
|
| Biotissue Holdings | Prokera | $48 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $21 | 1 payment
|
| Johnson & Johnson Surgical Vision | None | $19 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $18 | 1 payment
|
2022: $596
| Eyevance Pharmaceuticals | Tobradex St | $124 | 15 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $105 | 5 payments
|
| BioTissue Holdings | Prokera | $89 | 1 payment
|
| Abbvie | Durysta | $57 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $55 | 3 payments
|
| Glaukos | Istent Inject W | $48 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $34 | 2 payments
|
| Alcon Vision | Rhopressa | $25 | 1 payment
|
| Sight Sciences | Tearcare Smartlid | $23 | 1 payment
|
| Dompe US | Oxervate | $21 | 1 payment
|
| Allergan | Vuity | $16 | 1 payment
|
2021: $462
| Eyevance Pharmaceuticals | Tobradex St | $216 | 28 payments
|
| Kala Pharmaceuticals | Inveltys | $72 | 4 payments
|
| Aerie Pharmaceuticals | Rhopressa | $49 | 2 payments
|
| Tissuetech | Prokera | $40 | 2 payments
|
| Glaukos | Kxl System | $26 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $25 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $23 | 1 payment
|
| Allergan | Lumigan | $11 | 1 payment
|
2020: $592
| TissueTech | Prokera | $174 | 2 payments
|
| Eyevance Pharmaceuticals | Flarex | $164 | 28 payments
|
| Sun Pharmaceutical Industries | Bromsite | $91 | 4 payments
|
| Ivantis | Hydrus | $64 | 3 payments
|
| Aerie Pharmaceuticals | Rhopressa | $63 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $20 | 1 payment
|
| Allergan | Restasis | $17 | 1 payment
|
2019: $764
| Aerie Pharmaceuticals | Rhopressa | $199 | 6 payments
|
| Sun Pharmaceutical Industries | Bromsite | $183 | 4 payments
|
| Eyevance Pharmaceuticals | Flarex | $168 | 27 payments
|
| Bausch & Lomb a division of Bausch Health US | None | $76 | 1 payment
|
| Allergan | Lumigan | $63 | 3 payments
|
| Dompe US | Oxervate | $34 | 1 payment
|
| Alcon Vision | Restor | $24 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $17 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| RxSight Inc · Pmcs-002 · 2024 | Their institution | $40,000 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1013145127
- Licence
- CA A 114765California A114765: Current · expires 2028-09-30
- Trained
- Warren Alpert Medical School of Brown University, 2009
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1174 Castro St Ste 100, Mountain View, CA, 94040
- NPI first listed
- 2009-06-26
- NPI last updated
- 2014-07-11
This is when the NPI record was last certified, not a medical board exam.